ROCKVILLE, Md. — MaxCyte, Inc. (Nasdaq: MXCT), a leading cell engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it has appointed Sidharth Kapileshwar as Chief Corporate Development Officer. “Sidharth has a proven track record of building and scaling corporate development functions inside some […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) (“Bio-Techne”), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt the definitive agreement under which Merck KGaA, Darmstadt, Germany proposes to acquire Bio-Techne (the “Merger Agreement”) at a Special Meeting of Shareholders held today. “We are grateful to our […]
The acquisition will help expand AVS Bio’s biomaterials offering and ecommerce capabilities NORWICH, Conn. — AVS Bio (the “Company”), a leading global provider of critical inputs and services for the bioprocessing and biologics industries, today announced it has acquired Biorbyt Ltd. (“Biorbyt”), a global supplier of high-quality bio-reagents, antibodies, proteins, and other biomaterials for life […]
New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise Regional hub will support researchers and organizations across the DACH and broader EMEA regions Center strengthens collaboration, training and innovation within Europe’s life sciences community MINNEAPOLIS and DÜSSELDORF, Germany — Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic […]
New portfolio combines high-performance cell culture media, molecule-specific CQA optimization, and integrated CDMO capabilities to help biosimilar developers accelerate the path to analytical similarity and improve process economics. Pleasanton, Calif. – OPM Biosciences, a cell culture media and bioprocess solutions company, today announced two new offerings that extend its OPM-CHO™ platform into biosimilar development and […]
Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Thermo Fisher Scientific Co-founder and former CEO Dr Michael Chen transitions to Chief Scientific and Business Officer Cambridge, UK, and Boston, MA, USA — Nuclera, the biotechnology company enabling access to innovative protein technologies, today announced […]
HOUSTON — Elabscience® Bionovation Inc. (“Elabscience®” or “the Company”) launched EasySort™ Mouse CD4 Nanobeads on September 22, 2026, the Company’s first magnetic bead product for positive cell selection, designed to enrich mouse CD4+ cells for basic research. The product combines dextran-coated superparamagnetic beads measuring less than 40nm with high-affinity antibodies developed by Elabscience®. Internal validation showed […]
Agreement strengthens Sai Life Sciences’ discovery and development platforms with access to foundational CRISPR/Cas9 intellectual property, enabling responsible innovation and enhanced global partner support DUBLIN and HYDERABAD, India — ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced that it has signed a non-exclusive license agreement with Sai Life Sciences Limited (“Sai Life Sciences”), […]
Represents one of the largest ever human multi-omics data-generation efforts, integrating proteomic, genomic whole genome sequencing, and longitudinal clinical data One million whole-genome and proteomics sample dataset will help researchers identify early biological signals of disease and provide foundation for new discoveries in disease biology, diagnostics and therapeutics Initiative will leverage Advanced AI and large-scale […]
REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that David Horn, the Company’s President, Chief Financial Officer and Treasurer, will depart Seer effective October 1, 2026, to pursue a new opportunity at a private company. Charles Endweiss, who has […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
